ميرتازاپين تيڤع ۳٠ ملغ إسرائيل - العربية - Ministry of Health

ميرتازاپين تيڤع ۳٠ ملغ

teva pharmaceutical indust.ltd - mirtazapine 30 mg - tablets - mirtazapine - episode of major depression.

بيكالوتاميد تيڤع ٥٠ ملغ إسرائيل - العربية - Ministry of Health

بيكالوتاميد تيڤع ٥٠ ملغ

teva pharmaceutical indust.ltd - bicalutamide 50 mg - tablets - bicalutamide - for the treatment of advanced prostate cancer in combination with lhrh analog therapy or surgical castration.

بيكالوتاميد تيڤع ١٥٠ ملغ إسرائيل - العربية - Ministry of Health

بيكالوتاميد تيڤع ١٥٠ ملغ

teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.

نورميتن ١٠٠ إسرائيل - العربية - Ministry of Health

نورميتن ١٠٠

teva pharmaceutical indust.ltd - atenolol 100 mg - tablets - atenolol - management of angina pectoris and hypertension,including hypertension of renal origin. late intervention after acute myocardial infarction.

نورميتن ٥٠ إسرائيل - العربية - Ministry of Health

نورميتن ٥٠

abic ltd. - atenolol 50 mg - tablets - atenolol - management of angina pectoris and hypertension, including hypertension of renal origin. late intervention after acute myocardial infarction

تريؤولون إسرائيل - العربية - Ministry of Health

تريؤولون

abic ltd. - chloramphenicol 3 %; prednisolone 0.5 % - ointment - prednisolone - infected eczema, pruritic lesions, angular stomatitis, impetigo, external otitis and pyoderma and other skin infections caused by chloramphenicol susceptible organisms.

نورميتن ٢٥ إسرائيل - العربية - Ministry of Health

نورميتن ٢٥

abic ltd. - atenolol 25 mg - tablets - beta blocking agents, selective - management of angina pectoris and hypertension, including hypertension of renal origin. late intervention after acute myocardial infarction.

جلوكومين إسرائيل - العربية - Ministry of Health

جلوكومين

dexcel ltd - metformin hydrochloride 850 mg - caplets - metformin - treatment of non-insulin diabetes mellitus not responding to dietary modification.

ريپاݘلينيد تيڤع ١ ملغ إسرائيل - العربية - Ministry of Health

ريپاݘلينيد تيڤع ١ ملغ

teva pharmaceutical indust.ltd - repaglinide 1 mg - tablets - repaglinide - treatment of type ii diabetes.

لوساردكس٥٠ إسرائيل - العربية - Ministry of Health

لوساردكس٥٠

dexcel pharma technologies ltd - losartan potassium 50 mg - tablets - losartan - hypertension: losardex is indicated for the treatment of hypertension. heart failure: losardex is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex is not recommended. renal protection in type-2 diabetic patients with proteinuria: losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventric